NCT06178666View on ClinicalTrials.gov

A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2026

Conditions
Tuberculosis
Interventions
BIOLOGICAL

BCG

Three dose levels of intradermal BCG

Trial Locations (1)

BT3

Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
collaborator

Liverpool School of Tropical Medicine, United Kingdom

UNKNOWN

collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

University of Liverpool

OTHER

collaborator

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

OTHER

collaborator

University of Oxford

OTHER

lead

Liverpool School of Tropical Medicine

OTHER

NCT06178666 - A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi | Biotech Hunter | Biotech Hunter